Targeting the expression of T antigens with Selinexor (KPT‐330) shows promise for MCPyV‐positive Merkel cell carcinoma treatment
2013 ◽
Vol 133
(10)
◽
pp. 2453-2460
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 174
(4)
◽
pp. 813-822
◽
Keyword(s):